Hormone Replacement Therapy

Less Heart Disease, More Stroke Risk: What's a Girl to Do?

Published in Women's Health Weekly, January 11th, 2001

- by Maryclaire Lindgren, staff medical writer -- Postmenopausal hormone therapy decreases the risk of coronary events in women, even at the lower 0.3 mg dose of oral conjugated estrogen, however, estrogen doses at the standard 0.625 mg dose or higher increase a woman's stroke risk.

So, given this information, what should a woman do' Francine Grodstein, ScD, of the Channing Laboratory, Brigham and Women's Hospital, Massachusetts, and associates recently released data relating to issues involved in the decision to use or not use hormone therapy.

The results of their investigation of type, dose, and duration of the use of postmenopausal hormone...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2001-01-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry